Rachel Eguia

3.8k total citations · 2 hit papers
13 papers, 1.6k citations indexed

About

Rachel Eguia is a scholar working on Infectious Diseases, Animal Science and Zoology and Epidemiology. According to data from OpenAlex, Rachel Eguia has authored 13 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 4 papers in Animal Science and Zoology and 4 papers in Epidemiology. Recurrent topics in Rachel Eguia's work include SARS-CoV-2 and COVID-19 Research (10 papers), Viral gastroenteritis research and epidemiology (4 papers) and Influenza Virus Research Studies (4 papers). Rachel Eguia is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Viral gastroenteritis research and epidemiology (4 papers) and Influenza Virus Research Studies (4 papers). Rachel Eguia collaborates with scholars based in United States, South Africa and Australia. Rachel Eguia's co-authors include Jesse D. Bloom, Katharine H. D. Crawford, Adam S. Dingens, Andrea N. Loes, Helen Y. Chu, Neil P. King, Caitlin R. Wolf, Deleah Pettie, David Veesler and M. Alejandra Tortorici and has published in prestigious journals such as Cell, Nature Communications and The Journal of Infectious Diseases.

In The Last Decade

Rachel Eguia

13 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

2020 568 citations Allison J. Greaney, Tyler N. Starr et al. Cell Host & Microbe profile →
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

2020 435 citations Katharine H. D. Crawford, Rachel Eguia et al. Viruses profile →

Peers

Rachel Eguia

ID

MB

ASZ

IMMUN

EPIDE

Andrea N. Loes United States

Keara D. Malone United States

Craig Schindewolf United States

Adam D. Nitido United States

Yi-Min Zheng United States

François Kien Hong Kong

Tandile Hermanus South Africa

Lucy Thorne United Kingdom

Zhiqiang Ku China

Rachel S. Nargi United States

Andrea N. Loes United States

Rachel Eguia

1.8k ×1.3

ID

757 ×1.7

MB

278 ×1.2

ASZ

283 ×1.5

IMMUN

143 ×0.7

EPIDE

Citations per year, relative to Rachel Eguia Rachel Eguia (= 1×) peers Andrea N. Loes

Countries citing papers authored by Rachel Eguia

Since Specialization

Citations

This map shows the geographic impact of Rachel Eguia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Eguia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Eguia more than expected).

Fields of papers citing papers by Rachel Eguia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Eguia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Eguia. The network helps show where Rachel Eguia may publish in the future.

Co-authorship network of co-authors of Rachel Eguia

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Eguia. A scholar is included among the top collaborators of Rachel Eguia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Eguia. Rachel Eguia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Eguia, Rachel, Juhye Lee, Hugh K. Haddox, et al.. (2024). Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin. Cell Host & Microbe. 32(8). 1397–1411.e11. 15 indexed citations

2.

Farrell, Ariana Ghez, Bernadeta Dadonaite, Allison J. Greaney, et al.. (2022). Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2. Viruses. 14(9). 2061–2061. 18 indexed citations

3.

Greaney, Allison J., Tyler N. Starr, Rachel Eguia, et al.. (2022). A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy. PLoS Pathogens. 18(2). e1010248–e1010248. 28 indexed citations

4.

Greaney, Allison J., Rachel Eguia, Tyler N. Starr, et al.. (2022). The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes. PLoS Pathogens. 18(6). e1010592–e1010592. 10 indexed citations

5.

Tortorici, M. Alejandra, Alexandra C. Walls, Anshu Joshi, et al.. (2022). Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein. Cell. 185(13). 2279–2291.e17. 39 indexed citations

6.

Eguia, Rachel, Katharine H. D. Crawford, Terry Stevens‐Ayers, et al.. (2021). A human coronavirus evolves antigenically to escape antibody immunity. PLoS Pathogens. 17(4). e1009453–e1009453. 135 indexed citations

7.

Malone, Keara D., et al.. (2021). Comprehensive Profiling of Mutations to Influenza Virus PB2 That Confer Resistance to the Cap-Binding Inhibitor Pimodivir. Viruses. 13(7). 1196–1196. 13 indexed citations

8.

Crawford, Katharine H. D., Adam S. Dingens, Rachel Eguia, et al.. (2020). Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. The Journal of Infectious Diseases. 223(2). 197–205. 152 indexed citations

9.

Dingens, Adam S., Katharine H. D. Crawford, Amanda Adler, et al.. (2020). Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak. Nature Communications. 11(1). 4378–4378. 44 indexed citations

10.

Crawford, Katharine H. D., Rachel Eguia, Adam S. Dingens, et al.. (2020). Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays. Viruses. 12(5). 513–513. 435 indexed citations breakdown →

11.

Greaney, Allison J., Tyler N. Starr, Pavlo Gilchuk, et al.. (2020). Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition. Cell Host & Microbe. 29(1). 44–57.e9. 568 indexed citations breakdown →

12.

Soh, Y. Q. Shirleen, Louise H. Moncla, Rachel Eguia, Trevor Bedford, & Jesse D. Bloom. (2019). Comprehensive mapping of adaptation of the avian influenza polymerase protein PB2 to humans. eLife. 8. 41 indexed citations

13.

Lee, Juhye, Rachel Eguia, Seth J. Zost, et al.. (2019). Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin. eLife. 8. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact